You are here

EPSSG

Ongoing

Two web based studies are  currently implemented:

 

Study RMS 2005 relative to the  Rhabdomyosarcoma treatment:

 

Specifications
State: on since october 2005
Customer: European Paediatric Soft Tissue sarcoma Study Group
Sponsor: Foundation Hope City
Coordinator of the Study: Doct. Gianni Bisogno - Haemotology and Oncology Division, Padua

Number of expected patients: 600
Number of patients  involved in the study: 1.124
Number of participant centres: 127
Number of participant countries: 20 (Austria, Czech Republic, Belgium, Denmark, Great Britain, Italy, Finland, France, Germany, Greece, Iceland, Ireland, Luxemburg, Holland, Norway, Polond, Portugal, Spain, Sweden, Switzerland)

 

Study NRSTS relative to the treatment  of non rhabdo localized Sarcomas

 

Specifications
State: on since January 2006
Customer: European Paediatric Soft Tissue sarcoma Study Group
Sponsor: Foundation Hope City
Coordinator of the Study: Doctor Andrea Ferrari - Paediatric Oncology, National Tumours Institute, Milan
Number of expected patients: 250
Number of patients involved in the study: 692
Number of participant centres: 103
Numbero of participant countries: 20 (Austria,  Czech Republic, Belgium, Denmark, Great Britain, Italy, Finland, France, Germany, Greece, Iceland, Irelanda, Luxemburg, Holland, Norway, Polan, Portugal, Spain, Sweden, Switzerland)

Objectives 

Achievement of a centralized information system for management and monitoring  of the European Registry  and of the study.
Objective of the study is the  evaluation of effectiveness in terms of reduction of the  "event free survival".

 

 

Partner 

University of Padua-Haematology and Oncology Division

Timing 

Project on sine october 2005.

Head of the project at Cineca 

Doctor Marisa De Rosa